BMRN — BioMarin Pharmaceutical Inc. stock price, charts and financials

QT43BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
60.72
+0.72+1.20%
OverviewShort InterestFilings
BMRNQT43BioMarin Pharmaceutical Inc.·NASDAQ
60.72+1.20%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 13, 20268-K/ACurrent report (amended)
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
May 21, 20264Statement of changes in beneficial ownership
May 11, 20264Statement of changes in beneficial ownership
May 05, 202610-QQuarterly report
May 04, 20268-KCurrent report
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 27, 20268-KCurrent report
Apr 23, 20268-KCurrent report
Apr 21, 2026DEFA14AAdditional proxy soliciting materials
Apr 21, 2026ARSAnnual report to shareholders
Apr 21, 2026DEF 14ADefinitive proxy statement
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 19, 20264Statement of changes in beneficial ownership
Mar 19, 20264Statement of changes in beneficial ownership
Mar 19, 20264Statement of changes in beneficial ownership
#1 / 25 of 393
Page
▼
/ 16